If there is deterioration of the condition after early surgery for ovarian cancer, it is usually necessary to take targeted drugs under the guidance of doctors. If the recovery condition is good, it is usually not necessary, and the specifics should follow the doctor’s instruction. Targeted drugs are clinically used to stop the growth of cancer cells, and achieve therapeutic effect through the interaction with specific molecular targets necessary for the occurrence of cancer and tumor growth. However, the drug also has certain side effects on the organism, which may cause the organism to have adverse reactions such as nausea, vomiting, headache and so on. Therefore, whether it is necessary to take targeted drugs after early surgery for ovarian cancer needs to be judged according to the actual condition of the organism, and it is suggested that patients should have regular review after early surgery for ovarian cancer and find out the problems and intervene in time, so as to avoid delaying the disease and other serious effects.